The Bone Marrow and Stem Cell Transplantation Program focuses on bringing new treatments while at the same time providing a personal and caring approach to the patient. Interest and expertise exists in the treatment of specific diseases such as: -lymphomas -myeloma -leukemias -breast cancer -solid tumors -hemoglobinopathies -autoimmune diseases

There are several broad areas of active research interest which are highlighted below: -Stem cell biology -Graft-versus-Host disease -Transplantation Immunology -Immune reconstitution -Adoptive Immunotherapy -Dendritic cell vaccines -Pharmacogenomics

This Program involves eight departments within the Duke University School of Medicine. Senior-level faculty are involved in each project. The clinical trials and basic research all center around activities of the Bone Marrow and Stem Cell Transplantation Program. However, the projects involve the clinical activities of medical oncologists, hematologists, pulmonologists, general surgeons, pharmacologists, radiologists, radiation oncologists, biostatisticians, as well as the related basic research activities including hematopoiesis, immunology, drug resistance and growth factors. Fellows participate actively in delivering direct healthcare to the patient as well as choosing any laboratory or clinically related research project. Mentoring is provided by at least one faculty member in the program. 

 

The Duke Adult Bone Marrow and Stem Cell Transplant Program